Aspira Women’s Health Holds Annual Stockholder Meeting

Aspira Women’s Health ( (AWHL) ) has provided an announcement.

On June 4, 2025, Aspira Women’s Health Inc. held its annual meeting of stockholders, where several key proposals were voted on. The stockholders elected six directors for a one-year term, approved executive compensation, the issuance of warrants, an amendment to the 2019 Stock Incentive Plan, and ratified the selection of BDO USA, LLP as the independent registered public accounting firm for 2025. These decisions reflect the company’s ongoing efforts to strengthen its governance and financial strategies, potentially impacting its market positioning and stakeholder confidence.

The most recent analyst rating on (AWHL) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Aspira Women’s Health stock, see the AWHL Stock Forecast page.

Spark’s Take on AWHL Stock

According to Spark, TipRanks’ AI Analyst, AWHL is a Neutral.

The most significant factor impacting the score is the company’s poor financial performance, highlighted by unprofitability and a high-risk financial structure with negative equity. Technical analysis shows weak long-term trends, and valuation is impacted by a negative P/E ratio and lack of dividends. These factors cumulatively result in a low overall stock score.

To see Spark’s full report on AWHL stock, click here.

More about Aspira Women’s Health

Aspira Women’s Health Inc. operates in the healthcare industry, focusing on women’s health. The company is known for its innovative diagnostic and bio-analytical solutions, primarily targeting ovarian cancer detection and other gynecologic diseases.

Average Trading Volume: 4,501,540

Technical Sentiment Signal: Strong Sell

Current Market Cap: $2.56M

Learn more about AWHL stock on TipRanks’ Stock Analysis page.